Ariadna Forray, MD

• Albert C Shaw
• Amanda Mele
• Angela Di Paola
• Charla Nich
• Dawn W Foster
• Jacob Tebes
• Jennifer Kapo
• John D Roberts
• Joy S. Kaufman
• Kimberly Yonkers
• Kristine Olson
• Laura Copela Maturo
• Lisa Fucito
• Mehmet Sofuoglu
• Paula Zimbrean
• Sandra Ann Springer
• Srinivas Muvvala
• Steve Martino

Tobacco Use Disorder; Cognitive Behavioral Therapy; Depression, Postpartum; Substance-Related Disorders; Postpartum Period; Motivational Interviewing

• Placental microRNA methylome signatures may serve as biomarkers and therapeutic targets for prenatally opioid-exposed infants with neonatal opioid withdrawal syndromeRadhakrishna U, Nath S, Uppala L, Veerappa A, Forray A, Muvvala S, Metpally R, Crist R, Berrettini W, Mausi L, Vishweswaraiah S, Bahado-Singh R. Placental microRNA methylome signatures may serve as biomarkers and therapeutic targets for prenatally opioid-exposed infants with neonatal opioid withdrawal syndrome Frontiers In Genetics 2023, 14: 1215472. DOI: 10.3389/fgene.2023.1215472.
• COVID-19 Traumatic Disaster Appraisal and Stress Symptoms Among Health Care WorkersOlson K, Fogelman N, Maturo L, Alvarado J, Ball S, Forray A, Hu M, Ivy M, Kapo J, Krystal J, Mayes L, Rohrbaugh R, Southwick S, Tebes J, Wassel B, Sinha R. COVID-19 Traumatic Disaster Appraisal and Stress Symptoms Among Health Care Workers Journal Of Occupational And Environmental Medicine 2022, 64: 934-941. PMID: 35959912, PMCID: PMC9640251, DOI: 10.1097/jom.0000000000002673.
• Gender differences among persons entering medication treatment for opioid use disorder in the communityDi Paola A, Taweh N, Biondi BE, Forray A, Frank CA, Shaw A, Springer SA. Gender differences among persons entering medication treatment for opioid use disorder in the community American Journal On Addictions 2022, 31: 390-395. PMID: 35652902, PMCID: PMC9463117, DOI: 10.1111/ajad.13304.
• Support Models for Addiction Related Treatment (SMART) for pregnant women: Study protocol of a cluster randomized trial of two treatment models for opioid use disorder in prenatal clinicsForray A, Mele A, Byatt N, Tobon A, Gilstad-Hayden K, Hunkle K, Hong S, Lipkind H, Fiellin DA, Callaghan K, Yonkers KA. Support Models for Addiction Related Treatment (SMART) for pregnant women: Study protocol of a cluster randomized trial of two treatment models for opioid use disorder in prenatal clinics PLOS ONE 2022, 17: e0261751. PMID: 35025898, PMCID: PMC8758001, DOI: 10.1371/journal.pone.0261751.
• Gender differences among criminal justice-involved persons living with HIV interested in extended-release naltrexone treatmentBiondi BE, Frank CA, Forray A, Springer SA. Gender differences among criminal justice-involved persons living with HIV interested in extended-release naltrexone treatment Substance Abuse 2021, 42: 905-911. PMID: 33750285, PMCID: PMC8455717, DOI: 10.1080/08897077.2021.1900984.
• Maternal opioid use disorder: Placental transcriptome analysis for neonatal opioid withdrawal syndromeRadhakrishna U, Nath SK, Vishweswaraiah S, Uppala LV, Forray A, Muvvala SB, Mishra NK, Southekal S, Guda C, Govindamangalam H, Vargas D, Gardella WG, Crist RC, Berrettini WH, Metpally RP, Bahado-Singh RO. Maternal opioid use disorder: Placental transcriptome analysis for neonatal opioid withdrawal syndrome Genomics 2021, 113: 3610-3617. PMID: 34352367, DOI: 10.1016/j.ygeno.2021.08.001.
• The Collision of Mental Health, Substance Use Disorder, and Suicide.Forray A, Yonkers KA. The Collision of Mental Health, Substance Use Disorder, and Suicide. Obstetrics And Gynecology 2021, 137: 1083-1090. PMID: 33957654, DOI: 10.1097/aog.0000000000004391.
• Placental DNA methylation profiles in opioid-exposed pregnancies and associations with the neonatal opioid withdrawal syndromeRadhakrishna U, Vishweswaraiah S, Uppala LV, Szymanska M, Macknis J, Kumar S, Saleem-Rasheed F, Aydas B, Forray A, Muvvala SB, Mishra NK, Guda C, Carey DJ, Metpally RP, Crist RC, Berrettini WH, Bahado-Singh RO. Placental DNA methylation profiles in opioid-exposed pregnancies and associations with the neonatal opioid withdrawal syndrome Genomics 2021, 113: 1127-1135. PMID: 33711455, DOI: 10.1016/j.ygeno.2021.03.006.
• Substance Use Disorder Detection Rates Among Providers of General Medical InpatientsSerowik KL, Yonkers KA, Gilstad-Hayden K, Forray A, Zimbrean P, Martino S. Substance Use Disorder Detection Rates Among Providers of General Medical Inpatients Journal Of General Internal Medicine 2020, 36: 668-675. PMID: 33111239, PMCID: PMC7947066, DOI: 10.1007/s11606-020-06319-7.
• The short-term impact on economic outcomes of SBIRT interventions implemented in reproductive health care settingsOlmstead TA, Martino S, Ondersma SJ, Gilstad-Hayden K, Forray A, Yonkers KA. The short-term impact on economic outcomes of SBIRT interventions implemented in reproductive health care settings Journal Of Substance Abuse Treatment 2020, 120: 108179. PMID: 33298305, PMCID: PMC7733031, DOI: 10.1016/j.jsat.2020.108179.
• Mobile Applications to Help Women Achieve Better Behavioral Health in the Postpartum PeriodFoster D, Forray A. Mobile Applications to Help Women Achieve Better Behavioral Health in the Postpartum Period 2020, 325-335. DOI: 10.1093/oxfordhb/9780190218058.013.28.
• The Educational Value of Outpatient Consultation-Liaison Rotations: A White Paper From the Academy of Consultation-Liaison Psychiatry Residency Education SubcommitteeZimbrean PC, Ernst CL, Forray A, Beach SR, Lavakumar M, Siegel AM, Soeprono T, Schwartz AC. The Educational Value of Outpatient Consultation-Liaison Rotations: A White Paper From the Academy of Consultation-Liaison Psychiatry Residency Education Subcommittee Journal Of The Academy Of Consultation-Liaison Psychiatry 2020, 61: 436-449. PMID: 32650995, PMCID: PMC7235569, DOI: 10.1016/j.psym.2020.05.004.
• Opioid Use in PregnancyTobon AL, Habecker E, Forray A. Opioid Use in Pregnancy Current Psychiatry Reports 2019, 21: 118. PMID: 31734808, DOI: 10.1007/s11920-019-1110-4.
• Implementing Motivational Interviewing for Substance Misuse on Medical Inpatient Units: a Randomized Controlled TrialMartino S, Zimbrean P, Forray A, Kaufman JS, Desan PH, Olmstead TA, Gilstad-Hayden K, Gueorguieva R, Yonkers KA. Implementing Motivational Interviewing for Substance Misuse on Medical Inpatient Units: a Randomized Controlled Trial Journal Of General Internal Medicine 2019, 34: 2520-2529. PMID: 31468342, PMCID: PMC6848470, DOI: 10.1007/s11606-019-05257-3.
• Assessment of an electronic and clinician-delivered brief intervention on cigarette, alcohol and illicit drug use among women in a reproductive healthcare clinicForray A, Martino S, Gilstad-Hayden K, Kershaw T, Ondersma S, Olmstead T, Yonkers KA. Assessment of an electronic and clinician-delivered brief intervention on cigarette, alcohol and illicit drug use among women in a reproductive healthcare clinic Addictive Behaviors 2019, 96: 156-163. PMID: 31100713, PMCID: PMC6579708, DOI: 10.1016/j.addbeh.2019.05.007.
• Perspective: Sistas In Science - Cracking the Glass Ceiling.Starlard-Davenport A, Rich A, Fasipe T, Lance EI, Adekola K, Forray A, Steed M, Fitzgerald A, Walker S, Pace BS. Perspective: Sistas In Science - Cracking the Glass Ceiling. Ethnicity & Disease 2018, 28: 575-578. PMID: 30405303, PMCID: PMC6200304, DOI: 10.18865/ed.28.4.575.
• Marijuana Use in Adults Living with Sickle Cell DiseaseRoberts JD, Spodick J, Cole J, Bozzo J, Curtis S, Forray A. Marijuana Use in Adults Living with Sickle Cell Disease Cannabis And Cannabinoid Research 2018, 3: 162-165. PMID: 30014039, PMCID: PMC6044416, DOI: 10.1089/can.2018.0001.
• A randomized controlled trial of screening and brief interventions for substance misuse in reproductive healthMartino S, Ondersma SJ, Forray A, Olmstead TA, Gilstad-Hayden K, Howell HB, Kershaw T, Yonkers KA. A randomized controlled trial of screening and brief interventions for substance misuse in reproductive health American Journal Of Obstetrics And Gynecology 2017, 218: 322.e1-322.e12. PMID: 29247636, PMCID: PMC6896206, DOI: 10.1016/j.ajog.2017.12.005.
• Association of Panic Disorder, Generalized Anxiety Disorder, and Benzodiazepine Treatment During Pregnancy With Risk of Adverse Birth OutcomesYonkers KA, Gilstad-Hayden K, Forray A, Lipkind HS. Association of Panic Disorder, Generalized Anxiety Disorder, and Benzodiazepine Treatment During Pregnancy With Risk of Adverse Birth Outcomes JAMA Psychiatry 2017, 74: 1145-1152. PMID: 28903165, PMCID: PMC5710298, DOI: 10.1001/jamapsychiatry.2017.2733.
• Progesterone for smoking relapse prevention following delivery: A pilot, randomized, double-blind studyForray A, Gilstad-Hayden K, Suppies C, Bogen D, Sofuoglu M, Yonkers KA. Progesterone for smoking relapse prevention following delivery: A pilot, randomized, double-blind study Psychoneuroendocrinology 2017, 86: 96-103. PMID: 28926762, PMCID: PMC5659923, DOI: 10.1016/j.psyneuen.2017.09.012.
• Substance use during pregnancyForray A. Substance use during pregnancy F1000Research 2016, 5: f1000 faculty rev-887. PMID: 27239283, PMCID: PMC4870985, DOI: 10.12688/f1000research.7645.1.
• See One, Do One, Order One: a study protocol for cluster randomized controlled trial testing three strategies for implementing motivational interviewing on medical inpatient unitsMartino S, Zimbrean P, Forray A, Kaufman J, Desan P, Olmstead TA, Gueorguieva R, Howell H, McCaherty A, Yonkers KA. See One, Do One, Order One: a study protocol for cluster randomized controlled trial testing three strategies for implementing motivational interviewing on medical inpatient units Implementation Science 2015, 10: 138. PMID: 26420671, PMCID: PMC4589113, DOI: 10.1186/s13012-015-0327-9.
• Substance Use in the Perinatal PeriodForray A, Foster D. Substance Use in the Perinatal Period Current Psychiatry Reports 2015, 17: 91. PMID: 26386836, PMCID: PMC4671272, DOI: 10.1007/s11920-015-0626-5.
• Perinatal substance use: A prospective evaluation of abstinence and relapseForray A, Merry B, Lin H, Ruger JP, Yonkers KA. Perinatal substance use: A prospective evaluation of abstinence and relapse Drug And Alcohol Dependence 2015, 150: 147-155. PMID: 25772437, PMCID: PMC4387084, DOI: 10.1016/j.drugalcdep.2015.02.027.
• Perinatal substance use: A prospective evaluation of abstinence and relapseForray A, Merry B, Ruger J, Yonkers K. Perinatal substance use: A prospective evaluation of abstinence and relapse Drug And Alcohol Dependence 2015, 146: e281. DOI: 10.1016/j.drugalcdep.2014.09.230.
• Progesterone for the reduction of cocaine use in post-partum women with a cocaine use disorder: a randomised, double-blind, placebo-controlled, pilot studyYonkers KA, Forray A, Nich C, Carroll KM, Hine C, Merry BC, Shaw H, Shaw J, Sofuoglu M. Progesterone for the reduction of cocaine use in post-partum women with a cocaine use disorder: a randomised, double-blind, placebo-controlled, pilot study The Lancet Psychiatry 2014, 1: 360-367. PMID: 25328863, PMCID: PMC4199242, DOI: 10.1016/s2215-0366(14)70333-5.
• Pregnant Women With Posttraumatic Stress Disorder and Risk of Preterm BirthYonkers KA, Smith MV, Forray A, Epperson CN, Costello D, Lin H, Belanger K. Pregnant Women With Posttraumatic Stress Disorder and Risk of Preterm Birth JAMA Psychiatry 2014, 71: 897-904. PMID: 24920287, PMCID: PMC4134929, DOI: 10.1001/jamapsychiatry.2014.558.
• Addressing the evidence for FDA nicotine replacement therapy label changes: a policy statement of the Association for the Treatment of Tobacco use and Dependence and the Society for Research on Nicotine and Tobacco.Fucito LM, Bars MP, Forray A, Rojewski AM, Shiffman S, Selby P, West R, Foulds J, Toll BA. Addressing the evidence for FDA nicotine replacement therapy label changes: a policy statement of the Association for the Treatment of Tobacco use and Dependence and the Society for Research on Nicotine and Tobacco. Nicotine & Tobacco Research 2014, 16: 909-14. PMID: 24919399, PMCID: PMC6281057, DOI: 10.1093/ntr/ntu087.
• Perinatal smoking and depression in women with concurrent substance useForray A, Gotman N, Kershaw T, Yonkers KA. Perinatal smoking and depression in women with concurrent substance use Addictive Behaviors 2013, 39: 749-756. PMID: 24447885, PMCID: PMC3944019, DOI: 10.1016/j.addbeh.2013.12.008.
• Antidepressant Use in Pregnant and Postpartum WomenYonkers KA, Blackwell KA, Glover J, Forray A. Antidepressant Use in Pregnant and Postpartum Women Annual Review Of Clinical Psychology 2013, 10: 369-392. PMID: 24313569, PMCID: PMC4138492, DOI: 10.1146/annurev-clinpsy-032813-153626.
• Motivational enhancement therapy coupled with cognitive behavioral therapy versus brief advice: a randomized trial for treatment of hazardous substance use in pregnancy and after deliveryYonkers KA, Forray A, Howell HB, Gotman N, Kershaw T, Rounsaville BJ, Carroll KM. Motivational enhancement therapy coupled with cognitive behavioral therapy versus brief advice: a randomized trial for treatment of hazardous substance use in pregnancy and after delivery General Hospital Psychiatry 2012, 34: 439-449. PMID: 22795046, PMCID: PMC3428516, DOI: 10.1016/j.genhosppsych.2012.06.002.
• Onset and exacerbation of obsessive-compulsive disorder in pregnancy and the postpartum period.Forray A, Focseneanu M, Pittman B, McDougle CJ, Epperson CN. Onset and exacerbation of obsessive-compulsive disorder in pregnancy and the postpartum period. The Journal Of Clinical Psychiatry 2010, 71: 1061-8. PMID: 20492843, PMCID: PMC4204467, DOI: 10.4088/jcp.09m05381blu.
• Prevalence of post-traumatic stress disorder in pregnant women with prior pregnancy complicationsForray A, Mayes LC, Magriples U, Epperson CN. Prevalence of post-traumatic stress disorder in pregnant women with prior pregnancy complications The Journal Of Maternal-Fetal & Neonatal Medicine 2009, 22: 522-527. PMID: 19488936, PMCID: PMC4109276, DOI: 10.1080/14767050902801686.